BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities

Reuters01-09

BRIEF-Tenaya <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces 2026 Strategic Priorities

Jan 9 (Reuters) - Tenaya Therapeutics Inc TNYA.O:

TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES
TENAYA THERAPEUTICS INC - RAISED $60 MILLION IN 4Q25 TO SUPPORT RUNWAY THROUGH MID-2027
TENAYA THERAPEUTICS - EXPECTS TO REPORT ONE-YEAR COHORT 1 DATA & EARLY COHORT 2 DATA FROM RIDGE-1 STUDY OF TN-401 FOR PKP2-ASSOCIATED ARVC IN H1 2026
TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-201 IN 2026
TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-401 IN H2 2026

Source text: ID:nGNX5xRRdC

Further company coverage: TNYA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602715243?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-09 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602715243","market":"fut","top_or_hot":-1,"title":"BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Tenaya <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces 2026 Strategic Priorities </title></head><body><p><span>Jan 9 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/TNYA\">Tenaya Therapeutics Inc</a> <span>TNYA.O</span>:</p><ul><li><p>TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES</p></li><li><p>TENAYA THERAPEUTICS INC - RAISED $60 MILLION IN 4Q25 TO SUPPORT RUNWAY THROUGH MID-2027</p></li><li><p>TENAYA THERAPEUTICS - EXPECTS TO REPORT ONE-YEAR <a href=\"https://laohu8.com/S/CHRT.UK\">COHORT</a> 1 DATA &amp; EARLY COHORT 2 DATA FROM RIDGE-1 STUDY OF TN-401 FOR PKP2-ASSOCIATED ARVC IN H1 2026</p></li><li><p>TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-201 IN 2026</p></li><li><p>TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-401 IN H2 2026</p></li></ul><p>Source text: <span>ID:nGNX5xRRdC</span></p><p>Further company coverage: <span>TNYA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-09 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Tenaya <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces 2026 Strategic Priorities </title></head><body><p><span>Jan 9 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/TNYA\">Tenaya Therapeutics Inc</a> <span>TNYA.O</span>:</p><ul><li><p>TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES</p></li><li><p>TENAYA THERAPEUTICS INC - RAISED $60 MILLION IN 4Q25 TO SUPPORT RUNWAY THROUGH MID-2027</p></li><li><p>TENAYA THERAPEUTICS - EXPECTS TO REPORT ONE-YEAR <a href=\"https://laohu8.com/S/CHRT.UK\">COHORT</a> 1 DATA &amp; EARLY COHORT 2 DATA FROM RIDGE-1 STUDY OF TN-401 FOR PKP2-ASSOCIATED ARVC IN H1 2026</p></li><li><p>TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-201 IN 2026</p></li><li><p>TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-401 IN H2 2026</p></li></ul><p>Source text: <span>ID:nGNX5xRRdC</span></p><p>Further company coverage: <span>TNYA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA9Y8BSS:1","article_id":"2602715243","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602715243","pubTimestamp":1767967317,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities Jan 9 (Reuters) - Tenaya Therapeutics Inc TNYA.O:TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONESTENAYA ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","TNYA":"Tenaya Therapeutics Inc","BK4139":"生物科技"},"translate_title":"简介-Tenaya Therapeutics宣布2026年战略重点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNYA":0.9},"content_text":"BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities Jan 9 (Reuters) - Tenaya Therapeutics Inc TNYA.O:TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONESTENAYA THERAPEUTICS INC - RAISED $60 MILLION IN 4Q25 TO SUPPORT RUNWAY THROUGH MID-2027TENAYA THERAPEUTICS - EXPECTS TO REPORT ONE-YEAR COHORT 1 DATA & EARLY COHORT 2 DATA FROM RIDGE-1 STUDY OF TN-401 FOR PKP2-ASSOCIATED ARVC IN H1 2026TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-201 IN 2026TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-401 IN H2 2026Source text: ID:nGNX5xRRdCFurther company coverage: TNYA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602715243","isCrawlerRequest":true}